Previous pharmacological studies have implicated serotonergic brain systems in opiate-withdrawal-precipitated conditioned place aversion. To assess this hypothesis, we tested the effects of either (i) ...

Woburn, MA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today the availability of Javadin™ (clonidine hydrochloride) oral solution, the only FDA-approved, ...

Woburn, MA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Javadin™ (clonidine hydrochloride) oral ...

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 Estrogen withdrawal ...